$2.79
+0.14 (+5.28%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,262.4% upside
Low Target
$44.11
Average Target
$65.91
High Target
$67.85
Current Price
$2.79
Current
$2.79
$2.79
Target
$65.91
$65.91
$44.11
$65.91 avg
$67.85
Scenario Analysis
Bear Case
$44.11
1,481.0%
Low target
Base Case
$65.91
+2,262.4%
Avg target
Bull Case
$67.85
+2,331.9%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$13.15
-78.8% from high
52-Week Low
$2.59
+7.7% from low
Target vs 52W High
$65.91
+401.2% vs high
Next Earnings Report
Nov 17, 2026 · After Market Close
9d
until earnings
EPS Est: $-0.32
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |